Cidofovir for BK Virus–Associated Hemorrhagic Cystitis: A Retrospective Study
Clinical Infectious Diseases2009Vol. 49(2), pp. 233–240
Citations Over TimeTop 10% of 2009 papers
Simone Cesaro, Hans H. Hirsch, Maura Faraci, Joanna Owoc‐Lempach, Anna Beltrame, Andrea Tendas, Ioannis Baltadakis, Jean‐Hughes Dalle, Yener Koç, Jacek Toporski, Jan Styczyński, M. Akif Yeşilipek, Werner Heinz, Maurizio Caniglia, Jelena Rascon, Axel A. Fauser, Mauricette Michallet, Lucía López‐Corral, Stefan Neuburger, Gloria Tridello, H. Einsele, European Group for Blood and Marrow Transplantation
Abstract
Cidofovir may be a potentially effective therapy for BKV-HC, but evidence supporting its use requires randomized controlled trials.
Related Papers
- → Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant(2007)129 cited
- → Intravesicular Cidofovir for the Treatment of Polyomavirus-Associated Hemorrhagic Cystitis(2012)28 cited
- → BK Virus-associated Hemorrhagic Cystitis in Pediatric Cancer Patients Receiving High-dose Cyclophosphamide(2007)19 cited
- 동종말초조혈모세포이식 후 발생한 BK 바이러스 출혈성 방광염의 Cidofovir 방광 내 주입 치험 1례(2009)
- Cidofovir Treatment of BK Virus Associated Hemorrhagic Cystitis in Recipients of Hematopoietic Stem Cell Transplants(2006)